Tag: NASDAQ:GALE

FB Nasdaq FB Facebook
Finance

Healthcare Movers: Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), Pernix Therapeutics (NASDAQ:PTX), Galena Biopharma (NASDAQ:GALE), Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) is lower after the company reported mixed Q4 and full-year 2013 earnings, as well as releasing results for its Phase 3 POISE trial. Shares are now down 10.71% at $412.75, but are still at the higher end of its 52-week range of $30.38 – $497.00 On Friday, Intercept (NASDAQ:ICPT) reported a loss per share of $0.64, compared to a loss of … Continue reading Healthcare Movers: Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), Pernix Therapeutics (NASDAQ:PTX), Galena Biopharma (NASDAQ:GALE), Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)

Mark DeFrance
Gilead Sciences GILD NASDAQ:GILD
BioTech

Biotech Most Volatile: Arca Biopharma (NASDAQ:ABIO), Galena Biopharma (NASDAQ:GALE), Progenics Pharmaceuticals (NASDAQ:PGNX), AVEO Pharmaceuticals (NASDAQ:AVEO)

ARCA biopharma, Inc. (NASDAQ:ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases announced that Dan Mitchell has been appointed to the Company’s Board of Directors. Arca Biopharma Inc. (NASDAQ:ABIO) stock performance was -2.31% in last session and finished the day at $2.11. Traded volume was 3.15 million shares in the last session and the average volume of the stock remained 862,287.00 shares. The beta … Continue reading Biotech Most Volatile: Arca Biopharma (NASDAQ:ABIO), Galena Biopharma (NASDAQ:GALE), Progenics Pharmaceuticals (NASDAQ:PGNX), AVEO Pharmaceuticals (NASDAQ:AVEO)

Kevin Long
BioTech

Biotech Losers: CytRx Corporation (NASDAQ:CYTR), Galena Biopharma (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

CytRx Corporation (NASDAQ:CYTR) reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR) stock performance was -12.76% in last session and finished the day at $4.17. Traded volume was 11,065,087 million shares in the last session and the average volume of the stock remained 3.51 … Continue reading Biotech Losers: CytRx Corporation (NASDAQ:CYTR), Galena Biopharma (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Chris Lewis
BioTech

Healthcare Active runners: Zogenix (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX), Galena Biopharma (NASDAQ:GALE), Gilead Sciences (NASDAQ:GILD)

Officials with Zogenix Inc. (NASDAQ:ZGNX), the San Diego-based maker of Zohydro, did not return a message seeking comment about the drug. The company is marketing the drug as the first extended-release hydrocodone pain reliever without acetaminophen, which can cause liver failure if taken in excess. Zogenix, Inc. (NASDAQ:ZGNX) stock performance was -14.18% in last session and finished the day at $3.84. Traded volume was 9.38million … Continue reading Healthcare Active runners: Zogenix (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX), Galena Biopharma (NASDAQ:GALE), Gilead Sciences (NASDAQ:GILD)

Kristen Barton